Iterum Therapeutics plc
(NASDAQ: ITRM)

Iterum Therapeutics Plc operates as a pharmaceutical company, which engages in the development and commercialization of sulopenem. The company was founded by Corey N. Fishman on June 24, 2015 and is headquartered in Dublin, Ireland.

0.610

+0.011 (+1.84%)
Range 0.591 - 0.625   (5.75%)
Open 0.600
Previous Close 0.599
Bid Price 1.150
Bid Volume 8
Ask Price 1.180
Ask Volume 12
Volume 481,697
Value -
Remark
Delayed prices. Updated at 12 Nov 2025 05:00.
Data powered by
View All Events

Loading Chart...

Please login to view stock data and analysis